Predicting Outcomes for MF/SS

Multiple prognostic variables were prospectively evaluated for 168 patients with advanced stage mycosis fungoides (MF) and Sézary syndrome (SS). Univariate analysis indicated that age, lymph node stage and serum lactate dehydrogenase (LDH) were significant for prognosis. Prognostic variables that were significantly associated with a worse overall survival were skin and node stage, age, large cell transformation and LDH. Patients receiving biologic response modifiers and histone deacetylase inhibitors first had a better survival (2.5 years) compared with those who received multi-agent chemotherapy (nine months). Read more here.

 

Global Database

Information by country, region and/or subtype on treatments, clinical trials and incidence/mortality rates.

Resource Library

Over 2,000 pieces of information on lymphoma diagnosis, treatment, research, support and lifestyle.

logo europe

WEIGH-IN WEDNESDAY

Are you aware cancer patients can experience chemo brain without ever receiving chemotherapy?

IN THE NODE

Updates

 

The information on this website is for general use only. Please consult your physician if you think you may have lymphoma or
require more detailed information on the best course of treatment for you.

Our website does not host any form of advertisement. Last updated: 03/27/18. Copyright © 2018 Lymphoma Coalition. All rights reserved.